Intravascular Imaging guided PCI Safer and more effective compared with angiography guidance

Previous studies have suggested that intravascular imaging-guided percutaneous coronary intervention (PCI) may reduce adverse events compared to angiography guidance alone. However, these studies lacked power to assess specific outcomes like all-cause death and myocardial infarction, and primarily used intravascular ultrasound rather than optical coherence tomography (OCT).

A recent systematic review and meta-analysis aimed to evaluate the comparative performance of intravascular imaging-guided PCI versus angiography-guided PCI, particularly with drug-eluting stents. This study was published in the journal Lancet by Prof. Gregg W Stone and colleagues.

The researchers conducted a comprehensive search of databases including MEDLINE, Embase, and Cochrane from inception to August 30, 2023, for randomized trials comparing intravascular imaging-guided PCI (intravascular ultrasound or OCT) with angiography-guided PCI. The primary endpoint was target lesion failure, including cardiac death, target vessel-myocardial infarction (TV-MI), or target lesion revascularization. Standard frequentist meta-analysis and network meta-analysis techniques were used to analyze direct and indirect data, respectively.

The key findings of the study were:

  • Twenty-two trials involving 15,964 patients were included, with a mean follow-up duration of 24.7 months.

  • Intravascular imaging-guided PCI demonstrated a decreased risk of target lesion failure compared to angiography-guided PCI (RR 0.71, 95% CI 0.63–0.80, p<0.0001).

  • This reduction was driven by decreased risks of cardiac death (RR 0.55, 95% CI 0.41–0.75, p=0.0001), TV-MI (RR 0.82, 95% CI 0.68–0.98, p=0.030), and target lesion revascularization (RR 0.72, 95% CI 0.60–0.86, p=0.0002).

  • Additionally, intravascular imaging guidance lowered the risks of stent thrombosis (RR 0.52, 95% CI 0.34–0.81, p=0.0036), all myocardial infarction (RR 0.83, 95% CI 0.71–0.99, p=0.033), and all-cause death (RR 0.75, 95% CI 0.60–0.93, p=0.0091).

  • Similar outcomes were observed for OCT-guided and intravascular ultrasound-guided PCI.

Intravascular imaging guidance, whether using OCT or intravascular ultrasound, improves both safety and effectiveness of PCI compared to angiography guidance alone. This approach reduces risks of death, myocardial infarction, repeat revascularization, and stent thrombosis, enhancing patient outcomes in coronary stent implantation procedures.

Reference:

Stone, G. W., Christiansen, E. H., Ali, Z. A., Andreasen, L. N., Maehara, A., Ahmad, Y., Landmesser, U., & Holm, N. R. Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis. Lancet,2024. https://doi.org/10.1016/s0140-6736(23)02454-6

Powered by WPeMatico

Zirconia-based single-tooth restorations are reliable alternative materials to metal-based restorations with favourable outcomes

Zirconia-based single-tooth restorations are reliable alternative materials to metal-based restorations with favorable outcomes suggests a new study published in the Journal of Evidence-Based Dental Practice.

The primary aim was to investigate the survival rate of zirconia versus metal abutments, and the secondary aim was the clinical outcomes of all-ceramic versus metal-ceramic crowns on single-tooth implants. Patients with tooth agenesis who participated in a previously published prospective clinical study with a three-year follow-up were recalled after five years. Biological variables included survival and success rate of implants, marginal bone level, modified Plaque and Sulcus Bleeding Index and biological complications. Technical variables included restoration survival rate, marginal adaptation and technical complications. The aesthetic outcome of crowns and peri-implant mucosa in addition to patient-reported outcomes were recorded. Descriptive analysis, linear mixed model for quantitative data, or generalized linear mixed model for ordinal categorical data were applied; significance was set to 0.05.

Results: Fifty-three patients (mean age 32.4 years), with 89 implants participated in the 5-year examination. The implants supported 50 zirconia abutments with 50 all-ceramic (AC) crowns and 39 metal abutments with 29 metal-ceramic (MC) and 10 AC crowns. Zirconia-based single-tooth restorations are reliable alternative materials to metal-based restorations with favorable biological and aesthetic outcomes, and few technical complications.

Reference:

Mandana Hosseini, Nils Worsaae, Klaus Gotfredsen. The survival rate of implant-supported, single-tooth restorations based on zirconia or metal abutment in patients with tooth agenesis: A 5-year prospective clinical study. Journal of Evidence-Based Dental Practice. 2024,101970, ISSN 1532-3382. https://doi.org/10.1016/j.jebdp.2024.101970.(https://www.sciencedirect.com/science/article/pii/S1532338224000022)

Keywords:

Zirconia-based, single-tooth restorations, alternative materials, metal-based restorations, favourable outcomes, Journal of Evidence-Based Dental Practice, survival rate; dental implant; Single-Tooth; dental abutments; dental crowns; zirconium dioxide, Mandana Hosseini, Nils Worsaae, Klaus Gotfredsen

Powered by WPeMatico

Posttraumatic Epilepsy linked to increased risk of long-term Dementia: JAMA

A recent study published in the Journal of American Medical Association uncovered alarming connections between posttraumatic epilepsy (PTE) and long-term dementia risk. While both head injuries and epilepsy have long been associated with cognitive impairments, this study looked into the specific risk posed by PTE on dementia development over extended periods.

The study was conducted by the Atherosclerosis Risk in Communities (ARIC) project spanned over 25 years with data collected until December 31, 2019 and examined a cohort of 12,558 participants from four U.S. communities. The participants were initially enrolled in the late 1980s with data analysis carried out from March 2023 to January 2024. The findings highlighted the long-term consequences of head injuries and subsequent epileptic seizures.

The key findings from the study revealed that individuals with PTE underwent a 4.56 times higher risk of developing dementia when compared to the individuals without head injury or epilepsy. Even when compared to individuals with only head injuries or nontraumatic epilepsy, the dementia risk associated with PTE remained significantly high. These results underscore the critical need for preventative measures targeting head injuries and epilepsy, especially considering their potentially devastating cognitive outcomes.

The secondary analyses of the study indicated consistent dementia risk associated with PTE regardless of factors such as the severity of the initial head injury. These findings highlight the urgency for further research into the mechanisms underlying PTE and the identification of risk factors for its development.

The study emphasized the importance of these findings that provide compelling evidence linking PTE to long-term cognitive decline. This underlines the necessity for comprehensive strategies to prevent head injuries and subsequent epilepsy, as well as targeted interventions to reduce the risk of PTE-related dementia.

Reference:

Schneider, A. L. C., Law, C. A., Gottesman, R. F., Krauss, G., Huang, J., Kucharska-Newton, A., Jensen, F. E., Gugger, J. J., Diaz-Arrastia, R., & Johnson, E. L. (2024). Posttraumatic Epilepsy and Dementia Risk. In JAMA Neurology. American Medical Association (AMA). https://doi.org/10.1001/jamaneurol.2024.0010

Powered by WPeMatico

Vitamin E Intake Reduces Risk of Non-Alcoholic Fatty Liver Disease:Study

Non-alcoholic fatty liver disease (NAFLD) has emerged as a prevalent chronic liver disorder with its severe manifestation which is often linked to oxidative stress. A recent study published in the Nature Scientific Reports uncovered promising evidence of the protective potential of Vitamin E against NAFLD.

This study utilized data from the National Health and Nutrition Examination Survey (2017–2020) to analyze the relationship between various forms of Vitamin E intake and the prevalence of NAFLD. The study focused on the dietary intake, supplementary use and total consumption of Vitamin E which found compelling associations with hepatic steatosis and NAFLD. This investigation included a total of 6122 participants and utilized liver ultrasound transient elastography to measure hepatic steatosis that represented as controlled attenuated parameter (CAP) scores. The diagnosis of NAFLD was based on specific CAP threshold values.

After meticulous adjustments for several covariates including demographics, lifestyle factors and medical conditions, this study unearthed significant inverse correlations between Vitamin E intake and NAFLD. The dietary Vitamin E intake demonstrated a robust protective effect against NAFLD with higher intake levels associated with reduced odds of the disease. Also, supplementary Vitamin E use expressed a notable inverse association with NAFLD prevalence, further suggesting its potential in reducing liver disease risk.

The findings also shed light on the importance of total Vitamin E intake by encompassing both dietary and supplemental forms in conferring protection against NAFLD. While the results showed a marginal improvement, it highlights the overall beneficial impact of Vitamin E on liver health. Also, the study highlighted variations in the protective effects of Vitamin E based on the presence of hyperlipidemia that suggests tailored approaches for different risk profiles. 

Reference:

Qi, X., Guo, J., Li, Y., Fang, C., Lin, J., Chen, X., & Jia, J. (2024). Vitamin E intake is inversely associated with NAFLD measured by liver ultrasound transient elastography. In Scientific Reports (Vol. 14, Issue 1). Springer Science and Business Media LLC. https://doi.org/10.1038/s41598-024-52482-w

Powered by WPeMatico

Exposure to air pollution during first three years of life linked with increased risk of childhood asthma: JAMA

USA: The cohort study of 5,279 children found that exposure to PM2.5 or NO2 air pollution during early childhood may lead to the development of childhood asthma. A higher risk was reported among minoritized families living in densely populated communities characterized by fewer resources and opportunities and multiple environmental coexposures.

“Mean nitrogen dioxide (NO2) and mean fine particulate matter (PM2.5) air pollution during the first three years of life were linked with asthma incidence by early and middle childhood, after adjusting for individual-level characteristics,” the researchers reported in their study published in JAMA Network Open.

The association of ambient pollution (NO2 or PM2.5) with incident asthma was modified by individual-level and community-level socioeconomic circumstances, including maternal education and race.

Air pollution is a near-ubiquitous exposure and contributes largely to disease and premature death in the world, including for children. Air pollution exposure has been consistently linked with respiratory morbidity, including exacerbation of asthma and wheezing in children. Various reviews on air pollution, asthma, and respiratory symptoms in children concluded that outdoor traffic pollution contributes to childhood asthma development. However, many studies lack the racial and ethnic, geographic, and socioeconomic diversity to evaluate susceptibility by individual-level and community-level contextual factors.

Against the above background, Antonella Zanobetti, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, and colleagues aimed to examine early life exposure to PM2.5 and NO2 air pollution and asthma risk by early and middle childhood. They also determined whether individual and community-level characteristics modify associations between air pollution exposure and asthma.

For this purpose, the researchers included children enrolled in cohorts participating in the Children’s Respiratory and Environmental Workgroup consortium. The location of the birth cohorts was throughout the US, recruited between 1987 and 2007, and followed up through 11 years.

The survival analysis was adjusted for parental asthma, mother’s education, child’s race and ethnicity, smoking during pregnancy, sex, neighbourhood characteristics, and cohort. Statistical analysis was performed from February 2022 to December 2023.

The study’s main outcomes were caregiver reports of physician-diagnosed asthma through early (age 4 years) and middle (age 11 years) childhood.

The study led to the following findings:

  • Among 5279 included children, 51.5% were male; 24.7% of children had asthma by 11 years of age, and 18.1% had asthma by 4 years of age.
  • Mean values of pollutants over the first 3 years of life were associated with asthma incidence.
  • A 1 IQR increase in NO2 (6.1 μg/m3) was associated with increased asthma incidence among children younger than 5 years (HR, 1.25) and children younger than 11 years (HR, 1.22).
  • A 1 IQR increase in PM2.5 (3.4 μg/m3) was associated with increased asthma incidence among children younger than 5 years (HR, 1.31) and children younger than 11 years (OR, 1.23).
  • Associations of PM2.5 or NO2 with asthma were increased when mothers had less than a high school diploma, among Black children, in communities with fewer child opportunities, and in census tracts with a higher percentage of Black population and population density; for example, there was a significantly higher association between PM2.5 and asthma incidence by younger than 5 years of age in Black children (HR, 1.60) compared with White children (HR, 1.17).

“Air pollution continues to be a global burden with adverse consequences on childhood health,” the researchers wrote.

“Lowering asthma risk in the US requires reduction and regulation of air pollution combined with the creation of greater educational, environmental, and health equity at a community level,” they concluded.

Reference:

Zanobetti A, Ryan PH, Coull BA, et al. Early-Life Exposure to Air Pollution and Childhood Asthma Cumulative Incidence in the ECHO CREW Consortium. JAMA Netw Open. 2024;7(2):e240535. doi:10.1001/jamanetworkopen.2024.0535

Powered by WPeMatico

COVID-19 vaccination linked to persistence of long-term health risks of COVID infection: Study

A recent study highlights the persistent risk of long-term health consequences following SARS-CoV-2 infection and the protective effects of COVID-19 vaccination. The findings were published in the recent edition of the Nature Communications journal that provide crucial insights into the ongoing pandemic.

This retrospective cohort study was conducted in Hong Kong analyzed data from a territory-wide public healthcare database and encompassed a total of 1,175,277 patients with SARS-CoV-2 infection. This research stratified individuals by their vaccination status and compared them to non-infected controls. Over the course of one year, this study meticulously evaluated the risk of clinical sequelae, cardiovascular complications and all-cause mortality.

The results revealed a progressive reduction in the risk of all-cause mortality among the patients with SARS-CoV-2 infection when compared to the control group. The patients who were fully vaccinated or had received booster doses expressed a notably lower risk of experiencing major cardiovascular diseases and all-cause mortality when compared to those who were unvaccinated or partially vaccinated. This protective effect was particularly evident within the first 30-90 days post-infection.

The individuals who had completed their vaccination series or received booster doses did not face a significant increase in health risks from 271 and 91 days after infection, respectively. On the contrary, the individuals who remained unvaccinated or incompletely vaccinated continued to endure a heightened risk of clinical sequelae for up to a year following SARS-CoV-2 infection. This real-world evidence highlights the effectiveness of COVID-19 vaccines in reducing the long-term health consequences of SARS-CoV-2 infection and its persistence.

Reference:

Lam, I. C. H., Zhang, R., Man, K. K. C., Wong, C. K. H., Chui, C. S. L., Lai, F. T. T., Li, X., Chan, E. W. Y., Lau, C. S., Wong, I. C. K., & Wan, E. Y. F. (2024). Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection. In Nature Communications (Vol. 15, Issue 1). Springer Science and Business Media LLC. https://doi.org/10.1038/s41467-024-45953-1

Powered by WPeMatico

Heart disease research challenges ‘one size fits all’ aspirin guidelines

Heart disease researchers have identified a group of patients in whom international guidelines on aspirin use for heart health may not apply.

In a study published in the renowned medical journal Circulation, the findings of a review of data from three clinical trials challenge current best practice for use of the drug for primary prevention of heart disease or stroke – otherwise known as atherosclerotic cardiovascular disease.

The research examined the results from clinical trials involving more than 47,000 patients in 10 countries, including the US, the UK and Australia, which were published in 2018.

The analysis focused on findings for a subgroup of 7,222 patients who were already taking aspirin before the three trials commenced. Those studied were at increased risk for cardiovascular disease and were taking aspirin to prevent the first occurrence of a heart attack or stroke.

The data showed a higher risk of heart disease or stroke-12.5% versus 10.4% – for patients who were on aspirin before the trials and who then stopped, compared to those who stayed on the drug.

Analyses also found no significant statistical difference in the risk for major bleeding between the two groups of patients.

The research was led by Professor J. William McEvoy, Established Professor of Preventive Cardiology at University of Galway and Consultant Cardiologist at Saolta University Health Care Group, in collaboration with researchers in University of Tasmania and Monash University, Melbourne.

Professor McEvoy said: “We challenged the notion that aspirin discontinuation is a one-size-fits-all approach.”

The research team noted results from observational studies which suggest a 28% higher risk of heart disease or stroke among adults who were prescribed aspirin to reduce the risk for a first heart attack or stroke, but who subsequently chose to stop taking the aspirin without being told to do so by their doctor.

Based in large part on three major clinical trials published in 2018, international guidelines no longer recommend the routine use of aspirin to prevent the first occurrence of heart attack or stroke.

Importantly, aspirin remains recommended for high-risk adults who have already had a heart disease or stroke event, to reduce the risk of a second event.

The move away from primary prevention aspirin in recent guidelines is motivated by the increased risk of major bleeding seen with this common medication in the three trials, albeit major bleeding is relatively uncommon on aspirin and was most obvious only among trial participants who were started on aspirin during the trial, rather than those who were previously taking aspirin safely.

These trials primarily tested the effect of starting aspirin among adults who have not previously been treated with the drug to reduce the risk of atherosclerotic cardiovascular disease. Less is known about what to do in the common scenario of adults who are already safely taking aspirin for primary prevention.

Professor McEvoy said: “Our findings of the benefit of aspirin in reducing heart disease or stroke without an excess risk of bleeding in some patients could be due to the fact that adults already taking aspirin without a prior bleeding problem are inherently lower risk for a future bleeding problem from the medication. Therefore, they seem to get more of the benefits of aspirin with less of the risks.

“These results are hypothesis-generating, but at present are the best available data. Until further evidence becomes available, it seems reasonable that persons already safely treated with low-dose aspirin for primary prevention may continue to do so, unless new risk factors for aspirin-related bleeding develop.”

Reference:

Ruth Campbell, Mark R. Nelson, John J. McNeill and John W. McEvoy, Outcomes After Aspirin Discontinuation Among Baseline Users in Contemporary Primary Prevention Aspirin Trials: A Meta-Analysis, Circulation, DOI: 10.1161/CIRCULATIONAHA.123.065420.

Powered by WPeMatico

Collagen patch cover applied to anastomotic site after laparoscopic colectomy may facilitate recovery of bowel function: Study

Collagen patch cover applied to anastomotic site after laparoscopic colectomy may facilitate recovery of bowel function suggests a new study published in the BMC Surgery.

Numerous factors can influence bowel movement recovery and anastomotic healing in colorectal surgery, and poor healing can lead to severe complications and increased medical expenses. Collagen patch cover (CPC) is a promising biomaterial that has been demonstrated to be safe in animal models and has been successfully applied in various surgical procedures in humans. This study. A retrospective review of medical records from July 2020 to June 2022 was conducted to identify consecutive patients who underwent laparoscopic colectomy. Patients who received CPC at the anastomotic site were assigned to the collagen group, whereas those who did not receive CPC were assigned to the control group. Results: Data from 241 patients (collagen group, 109; control group, 132) were analyzed. Relative to the control group, the collagen group exhibited a faster recovery of bowel function, including an earlier onset of first flatus (2.93 days vs. 3.43 days, p < 0.01), first defecation (3.73 days vs. 4.18 days, p = 0.01), and oral intake (4.30 days vs. 4.68 days, p = 0.04). CPC use was also associated with lower use of postoperative intravenous analgesics. The complication rates in the two groups did not differ significantly. CPCs can be safely and easily applied to the anastomotic site during laparoscopic colectomy, and can accelerate bowel movement recovery. Further studies on the effectiveness of CPCs in colorectal surgery involving larger sample sizes are required.

Reference:

Huang, PY., Tsai, MC., Kiu, KT. et al. Collagen patch cover facilitates recovery of bowel function after laparoscopic colectomy. BMC Surg 24, 66 (2024). https://doi.org/10.1186/s12893-024-02339-w

Keywords:

Collagen patch, cover, anastomotic site, laparoscopic colectomy, recovery, bowel function, BMC Surgery, Huang, PY., Tsai, MC., Kiu, K

Powered by WPeMatico

Simple hysterectomy non-inferior to radical hysterectomy for pelvic recurrence in women with low-risk cervical cancer: NEJM

Canada: A recent study published in the New England Journal of Medicine compared simple versus radical hysterectomy in women with low-risk cervical cancer.

The researchers found simple hysterectomy to be not inferior to radical hysterectomy concerning the 3-year incidence of pelvic recurrence in patients with low-risk cervical cancer. A simple hysterectomy was linked with a reduced risk of urinary incontinence or retention.

Retrospective data indicate that parametrial infiltration incidence is low in women with early-stage low-risk cervical cancer, which raises questions regarding the need for radical hysterectomy in these patients. However, there is a lack of data from large, randomized trials comparing outcomes of radical and simple hysterectomy.

To fill this knowledge gap, Marie Plante, the University of British Columbia, Vancouver, Canada, and colleagues conducted a multicenter, randomized, noninferiority trial comparing radical hysterectomy with simple hysterectomy including lymph-node assessment in patients with low-risk cervical cancer (lesions of ≤2 cm with limited stromal invasion).

The study’s primary outcome was cancer recurrence in the pelvic area (pelvic recurrence) at three years. The prespecified noninferiority margin for the between-group difference in pelvic recurrence at three years was 4 percentage points.

Based on the study, the researchers reported the following findings:

  • Among 700 patients who underwent randomization (350 in each group), the majority had tumours that were stage IB1 according to the 2009 International Federation of Gynecology and Obstetrics (FIGO) criteria (91.7%), that had squamous-cell histologic features (61.7%), and that were grade 1 or 2 (59.3%).
  • With a median follow-up time of 4.5 years, the incidence of pelvic recurrence at 3 years was 2.17% in the radical hysterectomy group and 2.52% in the simple hysterectomy group. Results were similar in a per-protocol analysis.
  • The incidence of urinary incontinence was lower in the simple hysterectomy group than in the radical hysterectomy group within 4 weeks after surgery (2.4% vs. 5.5%) and beyond 4 weeks (4.7% vs. 11.0%).
  • The incidence of urinary retention in the simple hysterectomy group was also lower than that in the radical hysterectomy group within 4 weeks after surgery (0.6% vs. 11.0%) and beyond 4 weeks (0.6% vs. 9.9%).

“In patients with low-risk cervical cancer, simple hysterectomy was not inferior to radical hysterectomy concerning the 3-year incidence of pelvic recurrence and was linked with a lower risk of urinary incontinence or retention,” the researchers wrote.

“The study findings challenge our current standards and provide evidence that in selected patients, simple hysterectomy appears to be safe, yielding oncologic outcomes similar to those of radical hysterectomy, but due to the specificity of the disease and patient factors certain points require additional analysis,” Pedro T. Ramirez, MD, chair of the department of obstetrics and gynaecology at Houston Methodist Hospital, wrote in an accompanying editorial.

He added, “It is critical to ensure that simple hysterectomy use is limited to patients having low-risk tumours and meeting the eligibility criteria for this conservative approach. Patients who do not meet such inclusion criteria should continue to be offered radical hysterectomy.”

Reference:

Plante M, Kwon JS, Ferguson S, Samouëlian V, Ferron G, Maulard A, de Kroon C, Van Driel W, Tidy J, Williamson K, Mahner S, Kommoss S, Goffin F, Tamussino K, Eyjólfsdóttir B, Kim JW, Gleeson N, Brotto L, Tu D, Shepherd LE; CX.5 SHAPE investigators; CX.5 SHAPE Investigators. Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer. N Engl J Med. 2024 Feb 29;390(9):819-829. doi: 10.1056/NEJMoa2308900. PMID: 38416430.

Powered by WPeMatico

Spontaneous breathing trial techniques: Pressure support tied to more successful extubations compared with T-piece, study finds

Canada: A systematic review and meta-analysis comprising 6716 critically ill adults and children suggested that pressure support (versus T-piece) spontaneous breathing trials (SBTs) are linked with more successful extubations without increasing the risk of reintubation.

“Patients undergoing pressure support compared with T-piece SBTs were more likely to be extubated successfully and more likely to pass a spontaneous breathing trial if the results of an outlier trial were excluded,” the researchers reported in their study published in JAMA Network Open.

About 40% of the time spent on mechanical ventilation is attributed to the weaning process. A randomized clinical trial and a systematic review suggested that weaning protocols shorten the length of stay (LOS) in intensive care units (ICUs), the weaning time, and the duration of mechanical ventilation. Patients typically undergo a spontaneous breathing trial to assess their capacity to breathe spontaneously with little or no support.

Spontaneous breathing trials aid clinicians in minimizing the invasive ventilation duration for patients and stimulate timely discussion regarding readiness for extubation.

Several techniques are commonly used to conduct SBTs, such as continuous positive airway pressure (CPAP), T-piece, automatic tube compensation (ATC; providing flow-dependent ventilator support to overcome the resistance of the endotracheal tube during inspiration and expiration), pressure support (PS) with or without positive end-expiratory pressure (PEEP), and more recently, high-flow oxygen (HFO; offering variable levels of CPAP depending on the flow rate used). However, considerable controversy exists regarding the best spontaneous breathing trial technique to use.

Against the above background, Karen E. A. Burns, Department of Critical Care, St. Michael’s Hospital, Unity Health Toronto, Toronto, Ontario, Canada, and colleagues aimed to summarize trials comparing alternative SBTs.

For this purpose, the researchers searched several online databases from inception to 2023 and 5 conference proceedings (from January 1990 to April 2023). They selected randomized trials directly comparing SBT techniques in critically ill adults or children and reporting at least 1 clinical outcome.

Paired reviewers independently screened citations, abstracted data and assessed quality for the systematic review and meta-analysis using PRISMA guidelines. Data pooling was done using random-effects models. The systematic review and meta-analysis identified 40 trials that included 6716 patients.

Primary outcomes were SBT success, extubation success, and reintubation.

The researchers reported the following findings:

  • Low-quality evidence (14 trials [n = 4459]) suggested that patients were not more likely to pass pressure support (PS) compared with a T-piece SBT (risk ratio [RR], 1.04), unless 1 outlier trial accounting for all heterogeneity was excluded (RR, 1.09 [13 trials; n = 3939]; moderate-quality evidence), but were significantly more likely to be successfully extubated (RR, 1.07; 16 trials [n = 4462]; moderate-quality evidence).
  • Limited data (5 trials [n = 502]) revealed that patients who underwent automatic tube compensation/continuous positive airway pressure compared with PS SBTs had a significantly higher successful extubation rate (RR, 1.10 [low-quality evidence]).
  • Compared with T-piece SBTs, high-flow oxygen SBTs (3 trials [n = 386]) had significantly higher successful extubation (RR, 1.06) and lower reintubation (RR, 0.37 [both low-quality evidence]) rates. Credible subgroup effects were not found.

“These findings suggest that critically ill adults or children undergoing pressure support compared with T-piece SBTs were more likely to pass an SBT and to be extubated successfully,” the researchers wrote. “Pressure support SBTs were not linked with an increased risk of reintubation.”

“Future investigations should include these findings and compare SBT techniques that maximize differences in inspiratory support,” they concluded.

Reference:

Burns KEA, Khan J, Phoophiboon V, et al. Spontaneous Breathing Trial Techniques for Extubating Adults and Children Who Are Critically Ill: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024;7(2):e2356794. doi:10.1001/jamanetworkopen.2023.56794

Powered by WPeMatico